Skip to main content
Clinical Trials/JPRN-UMIN000049766
JPRN-UMIN000049766
Completed
未知

A verification study of the alleviation effects on symptoms after recovery from COVID-19 by using AHCC (R) with activity of enhancing human immune function including anti-virus immunity: a randomized, placebo-controlled, double-blind, parallel-group comparison study - A verification study of the alleviation effects on symptoms after recovery from COVID-19 by using AHCC (R) with activity of enhancing human immune function including anti-virus immunity

ORTHOMEDICO Inc.0 sites44 target enrollmentMarch 31, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Healthy Japanese subjects
Sponsor
ORTHOMEDICO Inc.
Enrollment
44
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 31, 2023
End Date
January 28, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2\. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3\. Subjects currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4\. Subjects who suffered from diseases (e.g., lifestyle disease, cardiac diseases, cancer, or respiratory diseases) except for post\-COVID\-19 symptoms after recovery from COVID\-19 5\. Subjects who have been diagnosed with post\-COVID\-19 symptoms 6\. Subjects who use or take "Foods for Specified Health Uses," or "Foods with Functional Claims" in daily 7\. Subjects who are currently taking medications (including herbal medicines) and supplements 8\. Subjects who are allergic to medicines and/or the test food related products 9\. Subjects who are pregnant, lactating, or planning to become pregnant during this trial 10\. Subjects who suffer from COVID\-19 11\. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 12\. Subjects who are judged as ineligible to participate in this study by the physician

Outcomes

Primary Outcomes

Not specified

Similar Trials